Healthcare provider profile · identity verified

Luis Origel

Nurse Practitioner · MISSION HILLS, CA · NPI 1447672696

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	283	74
Gabapentin	Gabapentin	243	52
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	241	41
Amlodipine Besylate	Amlodipine Besylate	204	47
Metformin Hcl	Metformin Hcl	172	42
Losartan Potassium	Losartan Potassium	157	34
Lisinopril	Lisinopril	150	44
Tamsulosin Hcl	Tamsulosin Hcl	135	33
Carvedilol	Carvedilol	130	23
Levothyroxine Sodium	Levothyroxine Sodium	123	31
Furosemide	Furosemide	118	25
Donepezil Hcl	Donepezil Hcl	115	18
Meclizine Hcl	Meclizine Hcl	108	25
Quetiapine Fumarate	Quetiapine Fumarate	107	23
Clonidine Hcl	Clonidine Hcl	104	35
Albuterol Sulfate Hfa	Albuterol Sulfate	98	39
Ibuprofen	Ibuprofen	94	36
Eliquis	Apixaban	88	16
Metoprolol Succinate	Metoprolol Succinate	84	17
Rosuvastatin Calcium	Rosuvastatin Calcium	82	21
Alendronate Sodium	Alendronate Sodium	78	11
Famotidine	Famotidine	75	22
Simvastatin	Simvastatin	72	13
Pantoprazole Sodium	Pantoprazole Sodium	67	21
Sertraline Hcl	Sertraline Hcl	65	14
Hydrochlorothiazide	Hydrochlorothiazide	62	17
Diclofenac Sodium	Diclofenac Sodium	59	28
Metformin Er Gastric	Metformin Hcl	57	suppressed
Ezetimibe	Ezetimibe	56	11
Omeprazole	Omeprazole	55	16
Colchicine	Colchicine	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	47	11
Tavaborole	Tavaborole	45	suppressed
Vascepa	Icosapent Ethyl	45	13
Diclofenac Potassium	Diclofenac Potassium	42	12
Hydrocortisone Butyrate	Hydrocortisone Butyrate	42	11
Memantine Hcl	Memantine Hcl	40	suppressed
Zileuton Er	Zileuton	40	suppressed
Lorazepam	Lorazepam	39	17
Montelukast Sodium	Montelukast Sodium	39	11
Clopidogrel	Clopidogrel Bisulfate	38	14
Metoprolol Tartrate	Metoprolol Tartrate	37	13
Trazodone Hcl	Trazodone Hcl	35	14
Trulicity	Dulaglutide	35	suppressed
Valsartan	Valsartan	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Dihydroergotamine Mesylate	Dihydroergotamine Mesylate	34	suppressed
Linzess	Linaclotide	34	suppressed
Glipizide	Glipizide	30	suppressed
Icosapent Ethyl	Icosapent Ethyl	30	13
Benazepril Hcl	Benazepril Hcl	29	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	12
Fluticasone Propionate	Fluticasone Propionate	28	14
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	13
Azithromycin	Azithromycin	25	22
Diflorasone Diacetate	Diflorasone Diacetate	25	suppressed
Finasteride	Finasteride	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Baclofen	Baclofen	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Clemastine Fumarate	Clemastine Fumarate	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Atrovent Hfa	Ipratropium Bromide	16	suppressed
Methimazole	Methimazole	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Dimethyl Fumarate	Dimethyl Fumarate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Ozempic	Semaglutide	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Tradjenta	Linagliptin	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Prednisone	Prednisone	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error